BioNexus Gene Lab Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 08/14/2026 | 14.28 K | $27.00 K | 100.00% | 0.59% |
| UBS GROUP AG | 08/13/2026 | 101 | $197 | -56.28% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 1 | $2 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioNexus Gene Lab Corp institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of BioNexus Gene Lab Corp. The most heavily invested institutionals were:
HRT FINANCIAL LP: 14,283
UBS Group AG: 101
Caitong International Asset Management Co., Ltd: 1
WELLS FARGO & COMPANY/MN: 0
0.60% of BioNexus Gene Lab Corp stock is owned by institutional investors.
Institutional investors have bought a total of 14.39 K shares in the last 24 months. This purchase volume represents approximately $32.51 K in transactions.